News
Boehringer Ingelheim partners with Inflammasome Therapeutics to develop therapies for retinal diseases
Inflammasome is entitled to receive up to $160 million in up-front, research and development support and milestone gated development payments from Boehringer Ingelheim
18% GST on biotech research services removed
Bangalore, 21 September 2018: The government has removed the 18% GST ( goods and services tax) levied on research services provided to foreign companies by biotech companies based in India. This was a major un-competitive factor making Indian biotech services uncompetitive. ABLE has been championing the need for this exemption for the last 18 months.
Cabinet approves Promulgation of the Prohibition of Electronic Cigarettes Ordinance
Notably, the Indian Council of Medical Research (ICMR), in a recent white paper on the subject, also recommended a complete ban on e-cigarettes based on currently available scientific evidence.
